Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for TNF-alpha Inhibitors in Chinese RA
NCT02878161Phase 4Unknown
- Start
- Jan 2016
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies, Fc-Fusion Proteins
01
Overview
A Phase 4 trial of infliximab, etanercept, adalimumab in rheumatoid arthritis (RA). Status: unknown.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02878161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02878161.